Category
IRON CHELATORS
IRON CHELATORS
Consistent
Purity
Global-Ready
Molecules
Advanced
Manufacturing
Scalable
Production
Partnership
Support
Deferasirox API has been developed by ASANA Pharmaceutical as part of its hematology and chronic disease management portfolio. Deferasirox API, listed under CAS number 201530-41-8, is an oral iron chelator used in the treatment of chronic iron overload in patients receiving long-term blood transfusions, particularly those with thalassemia or other anemias.
ASANA Pharmaceutical is dedicated to the development and manufacturing of high-purity APIs for hematology and chronic care, including Deferasirox. With expertise in chelation chemistry and regulatory-grade actives, ASANA ensures global compliance and consistent quality across North America, Europe, and Asia, backed by a robust infrastructure and GMP-certified operations.
ASANA Pharmaceutical works in collaboration with transfusion centers, hospital networks, and pharmaceutical companies to deliver reliable iron chelation solutions. Deferasirox [CAS No. 201530-41-8] is an oral iron chelator used for the treatment of chronic iron overload in patients undergoing frequent blood transfusions, especially those with thalassemia or sickle cell disease. It plays a key role in ASANA’s chronic condition management portfolio. As the need for long-term iron chelation therapies continues to grow, ASANA is committed to delivering:
Deferasirox API are available on public databases such as Wikipidia!